TANIGUCHI Tooru | Department of Microbiology, Nagoya City University Medical School
スポンサーリンク
概要
関連著者
-
Yasuda Yoko
Department Of Bacteriology Nagoya City University Graduate School Of Medical Sciences
-
Tochikubo Kunio
Department Of Bacteriology Nagoya City University Graduate School Of Medical Sciences
-
TANIGUCHI Tooru
Department of Microbiology, Nagoya City University Medical School
-
Taniguchi Tooru
Department Of Microbiology Nagoya City University Medical School
-
Taniguchi Taketoshi
Laboratory Of Molecular Biology Medical Research Center Kochi Medical School
-
Goto Norihisa
Department Of Safety Research On Blood And Biological Products
-
Isaka Masanori
Department Of Bacteriology Nagoya City University Graduate School Of Medical Sciences
-
Maeyama Jun-ichi
Department Of Safety Research On Blood And Biological Products National Institute Of Infectious Dise
-
Kozuka Satoshi
Department Of Microbiology Nagoya City University Medical School
-
MATANO Keiko
Department of Microbiology, Nagoya City University Medical School
-
Matano Keiko
Department Of Microbiology Nagoya City University Medical School
-
Ohkuma Kunio
Human Vaccine Production Department The Chemo-sero-therapeutic Research Institute
-
GOTO Norihisa
Dept. of Safety Res. on Biologics, National Institute of Infectious Disdases
-
Goto Norihisa
Department Of Safety Research On Biologics National Institute Of Health
-
MAEYAMA Jun-ichi
Department of Safety Research on Blood and Biological Products, National Institute of Infectious Dis
-
OHKUMA Kunio
First Production Department, The Chem-Sero-Therapeutic Research Institute
-
MAEYAMA Jun-ichi
Dept. of Safety Research on Biologics, National Institute of Infectious Diseases
-
ISAKA Masanori
Dept. of Microbiology, Nagoya City University Medical School
-
TANIGUCHI Tooru
Dept. of Microbiology, Nagoya City University Medical School
-
KOZUKA Satoshi
Dept. of Microbiology, Nagoya City University Medical School
-
YASUDA Yoko
Dept. of Microbiology, Nagoya City University Medical School
-
TOCHIKUBO Kunio
Dept. of Microbiology, Nagoya City University Medical School
-
Goto Norihisa
Department of Oral Microbiology, Showa University School of Dentistry
-
YASUDA Yoko
Department of Perinatology and Neuroglycoscience, Institute for Developmental Research, Aichi Human
-
Honda Takeshi
Department of Bacterial Infections, Research Institute for Microbial Disease, Osaka University
-
TOCHIKUBO KUNIO
Department of Microaiology, Nagoya City University Medical School
-
Honda Takeshi
Department Of Bacterial Infections Research Institute For Microbial Disease Osaka University
-
YAMAMOTO Koichiro
Department of Bacterial Infections, Research Institute for Microbial Diseases, Osaka University
-
MOROKUMA Kazunori
Human Vaccine Production Department, The Chemo-Sero-Therapeutic Research Institute
-
Yamamoto Koichiro
Department Of Nutritional Science Faculty Of Health And Welfare Science Okayama Prefectural Universi
-
Yamamoto Koichiro
Department Of Bacterial Infections Research Institute For Microbial Diseases Osaka University
-
MOROKUMA Kazunori
First Production Department, The Chem-Sero-Therapeutic Research Institute
-
MATANO Keiko
Dept.of Microbiology, Nagoya City University Medical School
-
MIURA Yutaka
Dept.of Microbiology, Nagoya City University Medical School
-
Miura Yutaka
Dept.of Microbiology Nagoya City University Medical School
-
Morokuma K
Human Vaccine Production Department The Chemo-sero-therapeutic Research Institute
-
Honda Takeshi
Department Of Bacterial Infections Research Institute For Microbial Diseases Osaka University
著作論文
- The Gene Encoding the Prepilin Peptidase lnvolved in Biosynthesis of Pilus Colonization Factor Antigen III (CFA/III) of Human Enterotoxigenic Escherichia coli
- Effects of Recombinant Cholera Toxin B Subunit on IL-1β Production by Macrophages In Vitro
- Cytokine Responses to Recombinant Cholera Toxin B Subunit Produced by Bacillus brevis as a Mucosal Adjuvant
- O-25 Adjuvanticity and Safety of rCTB as a Nasal Mucosal Adjuvant.(Proceedings of the 27th Annual Meeting)
- Evaluation of Recombinant Cholera Toxin B Subunit as a Nasal Mucosal Adjuvant.